Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00453661 · ClinicalTrials.gov registry record

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

A clinical trial of Breast Cancer and Prostate Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
2,472
Enrollment target
1
Study location

NCT00453661 is a study of Breast Cancer and Prostate Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,472 participants, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00453661, a study of Breast Cancer and Prostate Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
2,472 participants
Enrollment target
1
Study location

Study Summary

The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.

Interventions

  • BEHAVIORAL Questionnaire
  • BEHAVIORAL Patient Navigator (PN)

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 2,472 participants
Start Date 2007-03
Est. Completion 2020-09-28

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00453661

The ClinicalTrials.gov registry entry for NCT00453661 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,472 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (12% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.

NCT00453661 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00453661 about?

NCT00453661 is a clinical study titled "Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities". The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.

What is the current status of trial NCT00453661?

This trial is currently completed. The enrollment target is 2,472 participants. The study started on 2007-03. Estimated completion is 2020-09-28.

What conditions does trial NCT00453661 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer.

What interventions are being tested in trial NCT00453661?

The interventions under investigation include: Questionnaire (BEHAVIORAL), Patient Navigator (PN) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00453661?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00453661 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.